These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 12904687)

  • 1. The ascidian dihydropyridine-resistant calcium channel as the prototype of chordate L-type calcium channel.
    Okamura Y; Izumi-Nakaseko H; Nakajo K; Ohtsuka Y; Ebihara T
    Neurosignals; 2003; 12(3):142-58. PubMed ID: 12904687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The maternal transcript for truncated voltage-dependent Ca2+ channels in the ascidian embryo: a potential suppressive role in Ca2+ channel expression.
    Okagaki R; Izumi H; Okada T; Nagahora H; Nakajo K; Okamura Y
    Dev Biol; 2001 Feb; 230(2):258-77. PubMed ID: 11161577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Key roles of Phe1112 and Ser1115 in the pore-forming IIIS5-S6 linker of L-type Ca2+ channel alpha1C subunit (CaV 1.2) in binding of dihydropyridines and action of Ca2+ channel agonists.
    Yamaguchi S; Zhorov BS; Yoshioka K; Nagao T; Ichijo H; Adachi-Akahane S
    Mol Pharmacol; 2003 Aug; 64(2):235-48. PubMed ID: 12869628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A genetic screen for dihydropyridine (DHP)-resistant worms reveals new residues required for DHP-blockage of mammalian calcium channels.
    Kwok TC; Hui K; Kostelecki W; Ricker N; Selman G; Feng ZP; Roy PJ
    PLoS Genet; 2008 May; 4(5):e1000067. PubMed ID: 18464914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of voltage-activated calcium channels in the early zebrafish embryo.
    Sanhueza D; Montoya A; Sierralta J; Kukuljan M
    Zygote; 2009 May; 17(2):131-5. PubMed ID: 19222870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DHP-insensitive L-type-like Ca channel of ascidian acquires sensitivity to DHP with single amino acid change in domain III P-region.
    Izumi-Nakaseko H; Yamaguchi S; Ohtsuka Y; Ebihara T; Adachi-Akahane S; Okamura Y
    FEBS Lett; 2003 Aug; 549(1-3):67-71. PubMed ID: 12914927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Voltage-dependent calcium channels.
    Lacinová L
    Gen Physiol Biophys; 2005 Jun; 24 Suppl 1():1-78. PubMed ID: 16096350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High affinity interaction of mibefradil with voltage-gated calcium and sodium channels.
    Eller P; Berjukov S; Wanner S; Huber I; Hering S; Knaus HG; Toth G; Kimball SD; Striessnig J
    Br J Pharmacol; 2000 Jun; 130(3):669-77. PubMed ID: 10821797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Voltage-dependent calcium channels--beyond dihydropyridine antagonists.
    Snutch TP; Sutton KG; Zamponi GW
    Curr Opin Pharmacol; 2001 Feb; 1(1):11-6. PubMed ID: 11712528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blockade of T-type voltage-dependent Ca2+ channels by benidipine, a dihydropyridine calcium channel blocker, inhibits aldosterone production in human adrenocortical cell line NCI-H295R.
    Akizuki O; Inayoshi A; Kitayama T; Yao K; Shirakura S; Sasaki K; Kusaka H; Matsubara M
    Eur J Pharmacol; 2008 Apr; 584(2-3):424-34. PubMed ID: 18331727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A potent 1,4-dihydropyridine L-type calcium channel blocker, benidipine, promotes osteoblast differentiation.
    Nishiya Y; Kosaka N; Uchii M; Sugimoto S
    Calcif Tissue Int; 2002 Jan; 70(1):30-9. PubMed ID: 11907705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular pharmacology of high voltage-activated calcium channels.
    Doering CJ; Zamponi GW
    J Bioenerg Biomembr; 2003 Dec; 35(6):491-505. PubMed ID: 15000518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-functional diversity of human L-type Ca2+ channel: perspectives for new pharmacological targets.
    Abernethy DR; Soldatov NM
    J Pharmacol Exp Ther; 2002 Mar; 300(3):724-8. PubMed ID: 11861774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel dihydropyridine with 3-aryl meta-hydroxyl substitution blocks L-type calcium channels in rat cardiomyocytes.
    Galvis-Pareja D; Zapata-Torres G; Hidalgo J; Ayala P; Pedrozo Z; Ibarra C; Diaz-Araya G; Hall AR; Vicencio JM; Nuñez-Vergara L; Lavandero S
    Toxicol Appl Pharmacol; 2014 Aug; 279(1):53-62. PubMed ID: 24844443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Voltage-dependent calcium influx mediates maturation of myofibril arrangement in ascidian larval muscle.
    Ohtsuka Y; Okamura Y
    Dev Biol; 2007 Jan; 301(2):361-73. PubMed ID: 16962575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism underlying the block of human Cav3.2 T-type Ca2+ channels by benidipine, a dihydropyridine Ca2+ channel blocker.
    Inayoshi A; Sugimoto Y; Funahashi J; Takahashi S; Matsubara M; Kusaka H
    Life Sci; 2011 May; 88(19-20):898-907. PubMed ID: 21466810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The 1,4-dihydropyridine nucleus: a pharmacophoric template part 1. Actions at ion channels.
    Triggle DJ
    Mini Rev Med Chem; 2003 May; 3(3):215-23. PubMed ID: 12570837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cloning of the Cav 1.3 (alpha1D) L-type Ca2+ channel from mouse and its expression in the liver.
    Okamoto T; Kobayashi T; Hino O
    Int J Mol Med; 2004 Apr; 13(4):573-6. PubMed ID: 15010858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of Ca2+ current inhibition by cilnidipine using a beta-subunit antisense oligonucleotide.
    Uchida R; Yamazaki J; Kitamura K
    Eur J Pharmacol; 2003 Apr; 466(1-2):53-62. PubMed ID: 12679141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antagonism of 4-substituted 1,4-dihydropyridine-3,5-dicarboxylates toward voltage-dependent L-type Ca2+ channels Ca V 1.3 and Ca V 1.2.
    Chang CC; Cao S; Kang S; Kai L; Tian X; Pandey P; Dunne SF; Luan CH; Surmeier DJ; Silverman RB
    Bioorg Med Chem; 2010 May; 18(9):3147-58. PubMed ID: 20382537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.